If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPatria Private Regulatory News (PPET)

Share Price Information for Patria Private (PPET)

Share Price is delayed by 15 minutes
Get Live Data
618.00    -24.00 (-3.74%)
Bid:
622.00
Ask:
642.00
Spread: 20.00 (3.215%)
Market Cap: £903.86m
PPET Live PriceLast checked at - London Stock Exchange

Intraday Patria Private Share Chart

Annual Overview from QuotedData

25 Feb 2025 14:19

RNS Number : 4185Y
Patria Private Equity Trust PLC
25 February 2025
 

Patria Private Equity Trust - Annual Overview from QuotedData

25th February 2025

Long-term success - near-term opportunity

Patria Private Equity Trust (PPET), which invests alongside some of the best-performing private equity managers, should be well-placed to benefit from an uptick in deal activity that has accompanied falling interest rates in most developed markets.

Following a bumper couple of years for private equity returns on the back of strong deal activity, the last two years have been leaner. However, more deals should pave the way for a recovery in returns.

PPET's recent positive results, combined with an increase in private equity activity levels in 2025, ought to drive a narrowing of PPET's significant discount. Moreso now that progress is being made on the cost-disclosure issues (regulatory requirements affecting transparency in investment funds) that have impacted all trusts, but particularly funds-of-funds (investment funds that invest in multiple other funds) such as PPET.

Full Research:

https://quoteddata.com/research/patria-private-equity-trust-long-term-success-near-term-opportunity-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Patria Private Equity Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUVASRVWUUUAR
Date   Source Headline
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSNet Asset Value(s)
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20262:44 pmRNSHolding(s) in Company
2nd Mar 202611:44 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20269:41 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 202612:39 pmRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20264:15 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSEstimated NAV at 31 December 2025
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 202610:38 amRNSDirector/PDMR Shareholding
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:03 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSAnnual Financial Report
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20264:38 pmRNSQuarterly Disclosure
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSNotice of Results
6th Jan 20267:00 amRNSEstimated NAV at 30 November 2025
29th Dec 20259:54 amRNS-REdison issues report on Patria Private Equity Trust (PPET)
1st Dec 20251:40 pmRNSDividend Declaration
1st Dec 20257:00 amRNSEstimated NAV at 31 October 2025
4th Nov 202510:23 amRNSEstimated NAV at 30 September 2025 - Amendment
4th Nov 20257:00 amRNSEstimated NAV at 30 September 2025
3rd Nov 20253:00 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:36 amRNSTotal Voting Rights
31st Oct 20252:53 pmRNS-RUpdate from QuotedData
9th Oct 20258:45 amRNSQuarterly Disclosure
9th Oct 20257:00 amRNSBoard Succession Planning
6th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSEstimated NAV at 31 August 2025
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.